A
ANIK
Anika Therapeutics Inc. Common Stock
$20.25
Current Price
1W
1M
3M
6M
1Y
All
AI analysis
Read what the AI thinks of Anika Therapeutics Inc. Common Stock in the app.
Analyses are generated by AI from public data and are not investment advice.
Get the app
Key figures
Dividend per share
—
Yield
—
EPS
-$0.27
P/E
—
Data as of Oct 8
Why it matters for the long term
Over 10-20 years, what drives a share up is the growth of its profits (EPS) + reinvested dividends. The P/E tells you whether you are paying a lot or a little for that growth. In short: rising EPS + reasonable P/E + growing dividend = good long-term candidate.
Upcoming events
Quarterly earnings
Expected EPS: $0.06
Oct 29
Posts
No posts about ANIK yet.
About Anika Therapeutics Inc. Common Stock
Anika Therapeutics is a US medical device company that makes treatments for joint pain and tissue repair. Its main products are injections based on hyaluronic acid, a natural gel-like substance found in joints, used to ease knee osteoarthritis pain. It also sells products that help repair cartilage and soft tissue. The company earns money by selling these products to hospitals, surgeons, and distribution partners.